Why the study?
Do blood pressure lowering medications improve mortality and clinical outcomes in patients with type 2 diabetes?
Do blood pressure lowering medications improve mortality and clinical outcomes in patients with type 2 diabetes?
Blood pressure lowering improves mortality and clinical outcomes in patients with type 2 diabetes, particularly when baseline blood pressure is 140 mm Hg or higher.
Answers are grounded in this paper and cite their sources.
Supports BP lowering in T2D with baseline BP ≥140 mm Hg; confirms mortality and outcome benefits across trials.
Among patients with type 2 diabetes, BP lowering was associated with improved mortality and other clinical outcomes with lower RRs observed among those with baseline BP of 140 mm Hg and greater. These findings support the use of medications for BP lowering in these patients.
No takes yet. Share an insight, caveat, or question.
Emdin et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: